Physician profile
Curtis Bow
NPI 1093738429
$1,006.15
in general payments reported to CMS, 2019-2025
10 companies · $645 in 2025
The $645 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $97.48 · 2024: $106 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $238.17 | 2021-2022 | |
| Abbott Laboratories | $200.89 | 2024-2025 | Freestyle Libre 3 |
| Abbvie INC. | $195.88 | 2025 | |
| Janssen Pharmaceuticals, INC | $159.93 | 2025 | Spravato |
| Lilly USA, LLC | $60.02 | 2024 | Zepbound, Mounjaro |
| Pfizer INC. | $54.29 | 2025 | |
| Exact Sciences Corporation | $34.88 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $24.16 | 2024 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Dexcom, INC. | $20.91 | 2025 | Dexcom G6 Transmitter |
| Integra Lifesciences Corporation | $17.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Bow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.